Only one study was identified which specifically analysed risks and benefits of combining metformin with other antidiabetic drugs, where risk of hypoglycaemia with the combination of metformin, sulfonylurea and insulin glargine compared to premixed insulin was decreased [35]. This evidence concerns the gene INS and Hypoglycemia.